Heat biologics, inc. (HTBX)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash Flows from Operating Activities
Net loss

-6,373

-3,289

-6,330

-4,944

-5,819

-5,127

-3,923

-4,011

-3,528

-

-

-3,309

-3,240

-3,543

-1,663

-3,032

-4,734

-6,764

-5,427

-4,902

-4,026

-3,734

-3,127

-2,958

-2,422

-2,117

-2,029

-1,674

-788

Adjustments to reconcile net loss to net cash used in operating activities:
Goodwill impairment loss

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

67

-

-

-

67

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash lease expense

24

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash interest expense

4

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash investor relations expense

66

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash consideration for rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Stock-based compensation

948

337

485

386

2,060

135

140

140

371

142

143

153

248

122

118

130

211

527

259

348

438

343

224

328

169

194

193

156

26

Depreciation

-

-

-

-

-

-

62

64

44

33

34

33

33

33

33

33

32

30

30

28

25

25

20

18

2

3

1

0

0

Amortization of deferred financing costs and debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

141

25

25

25

25

25

25

25

24

13

0

0

0

24

2

0

Amortization of held to maturity investment premium

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

4

28

39

42

36

23

-

-

-

-

-

-

-

-

Amortization of bond premium

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64

50

0

0

0

Change in fair value of common stock warrants

977

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

-13

0

20

-91

21

115

-14

Change in fair value of contingent consideration

-27

-115

502

112

114

-170

114

539

11

224

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain on investments

-34

-0

0

0

5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash arising from changes in assets and liabilities:
Accounts receivable

110

-2

-40

-1

50

-39

54

8

-9

13

-8

8

-80

82

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Stock subscription receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35

Other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13

Prepaid expenses and other current assets

120

-315

51

-134

-142

-1,515

-1,530

2,349

-305

32

1,660

-6

-61

-271

173

-203

-231

-125

180

-275

252

115

80

-194

-203

266

300

335

106

Deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

50

-

-

-

-

-

-

-

-

Related party receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

5

7

6

5

4

3

16

-9

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

-24

0

0

Deferred financing costs

-

-

-

-

-

0

0

-40

10

-16

46

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-308

-441

-33

360

643

-0

156

-879

667

-180

206

-644

442

-204

37

-1,028

-494

1,027

184

-14

-555

687

-39

341

-273

259

-729

260

356

Deferred revenue

-901

3,410

0

-340

-691

-2,058

-1,840

-1,143

-752

6,088

-470

1,409

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

-225

-235

-205

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

45

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other liabilities

-348

324

187

226

-729

147

86

-112

-717

1,281

292

-216

-551

488

-281

-396

-352

-219

897

443

-81

359

126

-58

-124

345

-54

41

41

Other long-term liabilities

14

-306

12

32

47

25

32

-4

0

-289

10

18

-39

22

42

137

109

137

0

12

0

-

-

-

-

-

-

-

-

Deposits

-271

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-25

3

-21

10

18

Net Cash Used in Operating Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,950

-4,942

-5,069

-4,167

-3,747

-4,462

-

-

-

-

-

-

-

-

Net Cash Used in Operating Activities

-5,780

-252

-4,347

-4,061

-4,175

-5,998

-3,939

-7,969

-3,804

3,105

-3,986

-2,555

-2,965

-

-

-

-

-

-

-

-

-

-

-

-2,391

-1,623

-2,871

-1,389

-504

Cash Flows from Investing Activities
Proceeds from maturities of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,855

4,801

13

1,975

5,156

7,811

4,796

4,196

9,148

482

0

0

0

0

Purchase of short-term investments

26

30

34

37

35

-

-

-

-

-

-

-

-

-

-

-

-

0

848

2,324

7,917

3,415

5,477

3,305

0

17,347

0

0

0

Purchase of property and equipment

30

121

97

0

45

-

-

48

419

0

46

9

5

0

2

12

30

8

3

95

8

6

4

443

5

44

5

0

0

Proceeds from disposal of property and equipment

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash (Used in) Provided by Investing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,842

4,770

4

1,123

2,737

-114

-

-

-

-

-

-

-

-

Net Cash Used in Investing Activities

-54

-42

-132

-37

-81

-5,616

-80

-48

-419

-0

-46

-478

-5

-

-

-

-

-

-

-

-

-

-

-

477

-17,392

-5

0

0

Cash Flows from Financing Activities
Proceeds from public offering of common stock and warrants, net of issuance costs

6,600

-

-

-

-

-

-

-

-

2,446

0

0

4,183

0

0

0

6,287

-

-

-

-

-

-

-

-

-

-

-

0

Borrowings on line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments on notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments on line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Issuance of convertible notes payable, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

268

Proceeds from the issuance of common stock, net of underwriting discounts and commissions

11,428

-

-

-

-

43

293

0

3,573

0

1

104

2,357

4,054

3,027

0

0

-

-

-

11,400

-

0

0

0

-

-

-

0

Proceeds from issuance of long term debt, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

200

Payments on long term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

3,022

2,306

806

806

413

145

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

0

0

36

53

0

0

0

Stock issuance costs

452

-

-

-

-

1,072

8

1,875

173

85

0

25

214

101

196

0

190

-0

0

31

270

0

0

0

0

2

796

16

129

Repayments on principal of finance lease

24

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Provided by Financing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-806

5,289

1,815

-145

2,211

11,129

-

-

-

-

-

-

-

-

Net Cash Provided by Financing Activities

17,551

-

-

-

-

12,771

284

23,663

3,399

2,361

1

79

6,326

-

-

-

-

-

-

-

-

-

-

-

36

3

23,439

-484

5,388

Effect of exchange rate changes on cash and cash equivalents

-16

-

-

-

-0

-

-

-

-

-

-

-

-

109

-67

54

-82

-21

-51

-19

3

0

0

0

0

-

-

-

-

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-

-

-

-

-

-

35

53

21

-

-26

72

-67

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Change in Cash and Cash Equivalents

11,698

-294

-4,493

-4,068

-4,257

1,191

-3,699

15,698

-801

5,474

-4,057

-2,883

3,287

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net Increase in Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-621

1,349

-2,860

5,035

-3,270

-3,240

1,180

6,556

432

-2,701

3,293

-1,876

-19,011

20,562

-1,873

4,884

Supplemental Disclosure for Cash Flow Information:
Operating lease right-of-use assets obtained with lease liabilities

-

-

-

-

520

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance lease right-of-use assets obtained with lease liabilities

173

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

98

110

4

158

48

50

23

8

0

0

9

34

11

5

Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable

160

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Allocation of proceeds from public offering to warrant liabilities

2,494

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cashless exercise of warrants classified as liabilities

2,724

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cashless exchange of warrants classified as liabilities

773

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cancellation of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Non-cash consideration for rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Non-cash consideration for rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Non-cash conversion of preferred stock into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Beneficial conversion charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,300

0

Notes payable converted to Series A preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Conversion of convertible note payable to accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

197

0

Preferred conversion of preferred stock into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cashless exercise of stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Issuance of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0